Cross-Sector entity
Monsanto is most often covered alongside Bayer, which appears in 2 of these 2 stories. The clearest coverage concentration is pharma: 1 of 2 stories, with the rest divided among 1 other category. Monsanto appears in 2 tracked Cross-Sector stories from February 18, 2026.
2 verified stories tracked
Last mentioned: Feb 18, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Monsanto is most often covered alongside Bayer, which appears in 2 of these 2 stories. The clearest coverage concentration is pharma: 1 of 2 stories, with the rest divided among 1 other category. Monsanto appears in 2 tracked Cross-Sector stories from February 18, 2026. The tracked stories average 2 original sources each.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Monsanto. Shared-story counts are live from our verified record — not editorial picks.
End of Certainty Period
The 21-year structured resolution period is slated to conclude.
$7.25B Settlement Announced
Bayer agrees to a new $7.25 billion deal with a 21-year certainty plan.
Future Claims Deal
Bayer reaches a $7.25 billion agreement to resolve future litigation over a 21-year period.
Initial $10B Settlement
Bayer announces a massive settlement to resolve current claims, but future liability remains.
First Major Verdict
A California jury awards $289M to a groundskeeper, sparking a wave of litigation.
Monsanto Acquisition
Bayer completes $63 billion acquisition of Monsanto, inheriting Roundup litigation.
Bayer has reached a definitive $7.25 billion settlement to resolve future Roundup litigation, implementing a 21-year framework designed to provide financial and legal certainty. The deal aims to move the German conglomerate past the glyphosate-related liabilities that have weighed on its valuation since the 2018 Monsanto acquisition.
Bayer has reached a $7.25 billion settlement agreement to resolve long-standing litigation surrounding its Roundup herbicide. The deal includes a 21-year framework designed to provide legal and financial certainty for the company following years of costly courtroom battles.
